We are analyzing https://link.springer.com/article/10.1007/s002770050203.

Title:
Stromal abnormalities in neoplastic bone marrow diseases | Annals of Hematology
Description:
Bone marrow malignancies are clonal disorders resulting from neoplastic transformation of hematopoietic stem or progenitor cells. Similar to their normal counterparts, transformed blood-forming cells remain dependent on signals from the hematopoiesis-regulating stromal environment for survival and proliferation. There is increasing evidence that the microenvironment may also take a more active part in the disease process. A review of the literature on stromal abnormalities in the leukemias, the myelodysplastic syndromes, and multiple myeloma reveals three principal mechanisms by which stromal derangements can contribute to the evolution of a neoplastic disease. In the simplest case, neoplastic blood-forming cells induce reversible changes in stroma function or composition which result in improved growth conditions for the malignant cells (
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Social Networks
Mobile Technology & AI

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

article, cells, neoplastic, microenvironment, stromal, privacy, cookies, content, bone, marrow, stroma, access, information, publish, search, disease, data, log, journal, research, abnormalities, diseases, dührsen, hossfeld, multiple, myeloma, malignant, cell, nature, chapter, discover, springer, function, optional, personal, parties, policy, find, track, annals, hematology, review, cite, explore, hematopoietic, stem, similar, normal, bloodforming, part,

Topics {✒️}

stroma-related disease mechanisms multiple myeloma reveals hematopoiesis-regulating stromal environment month download article/chapter 'malignancy-induced microenvironment' 'malignancy-inducing microenvironment' privacy choices/manage cookies neoplastic cell population myelodysplastic syndromes myeloproliferative neoplasms full article pdf neoplastic disease european economic area scope submit manuscript clonal disorders resulting improved growth conditions alternative therapeutic approaches conditions privacy policy accepting optional cookies disease process related subjects neoplastic cells 'malignant microenvironment' hematopoietic microenvironment journal finder publish check access instant access article annals stroma system stromal abnormalities progenitor cells stroma function malignant cells stem cells neoplastic transformation privacy policy personal data article log microenvironment information normal counterparts stromal derangements books a optional cookies manage preferences hematology aims principal mechanisms subscription content article cite data protection

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Stromal abnormalities in neoplastic bone marrow diseases
         description: Bone marrow malignancies are clonal disorders resulting from neoplastic transformation of hematopoietic stem or progenitor cells. Similar to their normal counterparts, transformed blood-forming cells remain dependent on signals from the hematopoiesis-regulating stromal environment for survival and proliferation. There is increasing evidence that the microenvironment may also take a more active part in the disease process. A review of the literature on stromal abnormalities in the leukemias, the myelodysplastic syndromes, and multiple myeloma reveals three principal mechanisms by which stromal derangements can contribute to the evolution of a neoplastic disease. In the simplest case, neoplastic blood-forming cells induce reversible changes in stroma function or composition which result in improved growth conditions for the malignant cells ('malignancy-induced microenvironment'). In the second setting, functionally abnormal end cells derived from the malignant clone become an integral part of the stroma system, selectively stimulating the neoplastic cells and inhibiting normal blood cell formation ('malignant microenvironment'). In the third condition, the emergence of a neoplastic cell population is the consequence of a primary stroma lesion characterized by inability to control regular blood cell formation ('malignancy-inducing microenvironment'). The perception of different stroma-related disease mechanisms may eventually lead to the development of alternative therapeutic approaches.
         datePublished:
         dateModified:
         pageStart:53
         pageEnd:70
         sameAs:https://doi.org/10.1007/s002770050203
         keywords:
            Key words Bone marrow stroma
            Microenvironment
            Leukemia
            Myelodysplasia
            Multiple myeloma
            Hematology
            Oncology
         image:
         isPartOf:
            name:Annals of Hematology
            issn:
               1432-0584
               0939-5555
            volumeNumber:73
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:U. Dührsen
               affiliation:
                     name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
                     address:
                        name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. K. Hossfeld
               affiliation:
                     name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
                     address:
                        name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Stromal abnormalities in neoplastic bone marrow diseases
      description: Bone marrow malignancies are clonal disorders resulting from neoplastic transformation of hematopoietic stem or progenitor cells. Similar to their normal counterparts, transformed blood-forming cells remain dependent on signals from the hematopoiesis-regulating stromal environment for survival and proliferation. There is increasing evidence that the microenvironment may also take a more active part in the disease process. A review of the literature on stromal abnormalities in the leukemias, the myelodysplastic syndromes, and multiple myeloma reveals three principal mechanisms by which stromal derangements can contribute to the evolution of a neoplastic disease. In the simplest case, neoplastic blood-forming cells induce reversible changes in stroma function or composition which result in improved growth conditions for the malignant cells ('malignancy-induced microenvironment'). In the second setting, functionally abnormal end cells derived from the malignant clone become an integral part of the stroma system, selectively stimulating the neoplastic cells and inhibiting normal blood cell formation ('malignant microenvironment'). In the third condition, the emergence of a neoplastic cell population is the consequence of a primary stroma lesion characterized by inability to control regular blood cell formation ('malignancy-inducing microenvironment'). The perception of different stroma-related disease mechanisms may eventually lead to the development of alternative therapeutic approaches.
      datePublished:
      dateModified:
      pageStart:53
      pageEnd:70
      sameAs:https://doi.org/10.1007/s002770050203
      keywords:
         Key words Bone marrow stroma
         Microenvironment
         Leukemia
         Myelodysplasia
         Multiple myeloma
         Hematology
         Oncology
      image:
      isPartOf:
         name:Annals of Hematology
         issn:
            1432-0584
            0939-5555
         volumeNumber:73
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:U. Dührsen
            affiliation:
                  name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
                  address:
                     name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. K. Hossfeld
            affiliation:
                  name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
                  address:
                     name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Annals of Hematology
      issn:
         1432-0584
         0939-5555
      volumeNumber:73
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
      address:
         name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
         type:PostalAddress
      name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
      address:
         name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:U. Dührsen
      affiliation:
            name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
            address:
               name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
               type:PostalAddress
            type:Organization
      name:D. K. Hossfeld
      affiliation:
            name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
            address:
               name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
      name:Medizinische Klinik, Abteilung für Onkologie und Hämatologie, Universitätskrankenhaus Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany, , DE
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(27)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.92s.

LINK . SPRINGER . COM {}